Role of ionization of the phosphate cosubstrate on phosphorolysis by purine nucleoside phosphorylase (PNP) of bacterial (E. coli) and mammalian (human) origin

被引:0
|
作者
Anna Modrak-Wójcik
Aneta Kirilenko
David Shugar
Borys Kierdaszuk
机构
[1] University of Warsaw,Department of Biophysics, Institute of Experimental Physics
[2] Polish Academy of Sciences,Institute of Biochemistry and Biophysics
来源
关键词
Purine nucleoside phosphorylase; Phosphate; Thiophosphate; Ionic forms; Enzyme kinetics; pH effects;
D O I
暂无
中图分类号
学科分类号
摘要
Kinetics of the reactions of purine nucleoside phosphorylases (PNP) from E. coli (PNP-I, the product of the deoD gene) and human erythrocytes with their natural substrates guanosine (Guo), inosine (Ino), a substrate analogue N(7)-methylguanosine (m7Guo), and orthophosphate (Pi, natural cosubstrate) and its thiophosphate analogue (SPi), found to be a weak cosubstrate, have been studied in the pH range 5–8. In this pH range Guo and Ino exist predominantly in the neutral forms (pKa 9.2 and 8.8); m7Guo consists of an equilibrium mixture of the cationic and zwitterionic forms (pKa 7.0); and Pi and SPi exhibit equilibria between monoanionic and dianionic forms (pKa 6.7 and 5.4, respectively). The phosphorolysis of m7Guo (at saturated concentration) with both enzymes exhibits Michaelis kinetics with SPi, independently of pH. With Pi, the human enzyme shows Michaelis kinetics only at pH ∼5. However, in the pH range 5–8 for the bacterial enzyme, and 6–8 for the human enzyme, enzyme kinetics with Pi are best described by a model with high- and low-affinity states of the enzymes, denoted as enzyme-substrate complexes with one or two active sites occupied by Pi, characterized by two sets of enzyme-substrate dissociation constants (apparent Michaelis constants, Km1 and Km2) and apparent maximal velocities (Vmax1 and Vmax2). Their values, obtained from non-linear least-squares fittings of the Adair equation, were typical for negative cooperativity of both substrate binding (Km1 < Km2) and enzyme kinetics (Vmax1/Km1 > Vmax2/Km2). Comparison of the pH-dependence of the substrate properties of Pi versus SPi points to both monoanionic and dianionic forms of Pi as substrates, with a marked preference for the dianionic species in the pH range 5–8, where the population of the Pi dianion varies from 2 to 95%, reflected by enzyme efficiency three orders of magnitude higher at pH 8 than that at pH 5. This is accompanied by an increase in negative cooperativity, characterized by a decrease in the Hill coefficient from nH ∼1 to nH ∼0.7 for Guo with the human enzyme, and to nH ∼0.7 and 0.5 for m7Guo with the E. coli and human enzymes, respectively. Possible mechanisms of cooperativity are proposed. Attention is drawn to the substrate properties of SPi in relation to its structure.
引用
收藏
页码:153 / 164
页数:11
相关论文
共 36 条
  • [1] Role of ionization of the phosphate cosubstrate on phosphorolysis by purine nucleoside phosphorylase (PNP) of bacterial (E-coli) and mammalian (human) origin
    Modrak-Wojcik, Anna
    Kirilenko, Aneta
    Shugar, David
    Kierdaszuk, Borys
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2008, 37 (02): : 153 - 164
  • [2] PROPERTIES OF PURINE NUCLEOSIDE PHOSPHORYLASE (PNP) OF MAMMALIAN AND BACTERIAL ORIGIN
    BZOWSKA, A
    KULIKOWSKA, E
    SHUGAR, D
    ZEITSCHRIFT FUR NATURFORSCHUNG C-A JOURNAL OF BIOSCIENCES, 1990, 45 (1-2): : 59 - 70
  • [3] Cellulomonas sp. purine nucleoside phosphorylase (PNP) -: Comparison with human and E-coli enzymes
    Wielgus-Kutrowska, B
    Tebbe, J
    Schröder, W
    Luic, M
    Shugar, D
    Saenger, W
    Koellner, G
    Bzowska, A
    PURINE AND PYRIMIDINE METABOLISM IN MAN IX, 1998, 431 : 259 - 264
  • [4] Inhibitor screening for human purine nucleoside phosphorylase, bovine xanthine oxidase and E. coli thymidine phosphorylase
    Fridman, Frida
    Ringia, Erika A. Taylor
    Schramm, Vern L.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231
  • [5] In vivo antitumor activity of intratumoral fludarabine phosphate in refractory tumors expressing E. coli purine nucleoside phosphorylase
    Eric J. Sorscher
    Jeong S. Hong
    Paula W. Allan
    William R. Waud
    William B. Parker
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 321 - 329
  • [6] Design and evaluation of 5′-modified nucleoside analogs as prodrugs for an E. coli purine nucleoside phosphorylase mutant
    Parker, WB
    Allan, PW
    Ealick, SE
    Sorscher, EJ
    Hassan, AEA
    Silamkoti, AV
    Fowler, AT
    Waud, WR
    Secrist, JA
    NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS, 2005, 24 (5-7): : 387 - 392
  • [7] Three-dimensional structure of E. Coli purine nucleoside phosphorylase at 0.99 Å resolution
    V. I. Timofeev
    Yu. A. Abramchik
    N. E. Zhukhlistova
    T. I. Muravieva
    R. S. Esipov
    I. P. Kuranova
    Crystallography Reports, 2016, 61 : 249 - 257
  • [8] An Armed Oncolytic Vector (OV1203) expressing E. coli purine nucleoside phosphorylase (PNP) combined with Fludara™ shows increased efficacy
    Robinson, Michael J.
    Yendluri, Satya
    Laflamme, Genevieve
    Yu, Dc
    Parker, William B.
    Waud, William R.
    Jooss, Karin
    CANCER RESEARCH, 2006, 66 (08)
  • [9] Acyclovir molecule in the active site of E. coli purine nucleoside phosphorylase (on the basis of x-ray study)
    Kuranova, I.
    Timofeev, V.
    Zhukhlistova, N.
    Abramchik, Y.
    Muravieva, T.
    Esipov, R.
    FEBS JOURNAL, 2016, 283 : 198 - 198
  • [10] In vivo sensitization of ovarian tumors to chemotherapy by expression of E. coli purine nucleoside phosphorylase in a small fraction of cells
    V K Gadi
    S D Alexander
    J E Kudlow
    P Allan
    W B Parker
    E J Sorscher
    Gene Therapy, 2000, 7 : 1738 - 1743